The fake page used edited clips of Manila Doctors Hospital internist-cardiologist Dr. Anthony Leachon without permission ...

CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...

Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patien ...

Phase 3 epilepsy program advancing with X-TOLE2 topline FOS data anticipated in H2 2025– Long-term azetukalner results from X-TOLE open-label ...

Flare Tx logo ... Ph.D., Chief Scientific Officer and Co-founder of Flare Therapeutics. "We are excited to join forces with ...

Ronsheim, Ph.D. as Chief Operating Officer and a member of the Xenon ... pre-clinical and discovery programs to advance multiple potential drug candidates targeting Kv7, Nav1.7, and Nav1.1, and ...

Duterte withdrew the Philippines from ICC in 2019 in a move activists said was an attempt to evade accountability and prevent ...

Tempest Therapeutics (TPST) announced that the company received a “Study May Proceed” letter from the U.S. Food and Drug ...

Those ever-present TV drug ads showing patients hiking, biking, or enjoying a day at the beach could soon have a different ...

In March 2013, the government-run drug rehab Hanoi released Hung Quang Pham early. They didn’t want the bone-thin heroin user ...

The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical needs and treat serious conditions.